Ovarian Cancer

Management of STIC in Patients Undergoing RRSO

Ovarian Borderline Tumors

GYOEDU Resident: Ovarian Cancer Surveillance and Recurrences

HIPEC in ovarian cancer

Korean HIPEC trial

The addition of HIPEC after interval cytoreductive surgery following neoadjuvant chemotherapy provided significant improvements in PFS and OS.

Mucinous Ovarian Carcinoma

GOG 241: Phase III Randomized Trial in Patients with Mucinous Epithelial Ovarian Cancer

Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.

Germ Cell Tumors of the Ovary

Granulosa Cell Tumors

Secondary Debulking Mini-Tutorial